Typewriter Therapeutics is developing an RNA-based gene writing therapeutic platform.
Investors 1
| Date | Name | Website |
| - | AN Venture... | an.vc |
Mentions in press and media 2
| Date | Title | Description |
| 02.09.2026 | Typewriter Therapeutics Raises $56M in Series A Funding | Typewriter Therapeutics, a Cambridge, MA-based provider of a gene writing technology platform for genetic medicines, raised $56M in Series A financing. The round was led by AN Venture Partners and RA Capital Management with participation fr... |
| - | Typewriter Therapeutics | “Home - Typewriter Therapeutics” |